Hyperbaric oxygen therapy is here considered in the treatment of established or chronic osteomyelitis. This disease is still a problem as, despite treatment with modern antibiotics and early surgery, there still remains a residue of 10-15 % of acute infections which become chronic. To these are added an increasing number of infections following reconstructive joint surgery together with subacute infections of the axial skeleton in the elderly patient.
Hyperbaric oxygen therapy refers to the use of oxygen under increased pressure, usually two or three times atmospheric, which when inhaled increases the volume of dissolved oxygen in the plasma, even when the hemoglobin is fully saturated. At three atmospheres absolute pressure this volume reaches 6-5 ml % which is more than the tissues require for metabolism in the resting state.
The limitations of the therapy are imposed by its toxic effects on living tissues when used for long periods. Prolonged exposure to oxygen at low pressures produces toxic pneumonitis, while higher pressures in shorter exposures produce toxic effects in the central nervous system with muscle twitching and major convulsions if continued. In this series, a small single-patient chamber was used which is transparent, totally encloses the patient, and can be filled with oxygen at increased pressures.
Historically, hyperbaric oxygenation was first used in the treatment of anaerobic bacterial infections, particularly the clostridial infections causing gas gangrene. In vitro experiments have shown that a wide rangc of aerobic pathogenic organisms, including Staph. pyogenes, could be temporarily inhibited when cultured in hyperbaric oxygen for 18-24 hours but that normal growth resumed when it was discontinued (Hopkinson & Towers 1963) . These results led to its use in experimental staphylococcal infections in animals, but the results with soft-tissue wound infections were disappointing due to the short exposures permitted before the onset of toxic effects. The reports of its success in the treatment of clinical chronic osteomyelitis (Slack et al. 1965 , Perrins et al. 1966 led to a study being made of experimental staphylococcal osteomyelitis in rats (Hamblen 1968 ). The investigation was in two parts in order to study the effect of the therapy on developing and established infection. Treatment for seven days following the inoculation of a standard dose of staphylococcus into the medulla of the rat's tibia failed to inhibit bacterial growth, confirming the in vitro findings. More success was obtained in the treatment of established 21-day-old infections, which clinically and radiologically fulfilled the criteria of chronic osteomyelitis. Treatment at two or three atmospheres pressure was continued for 21 days by intermittent exposures for one to two hours twice or three times daily. Results were assessed on bacteriological, histological and X-ray findings. Of interest with regard to later experience in the treatment of clinical cases were the absorption and extrusion of cortical sequestra and the repair of massive bone destruction even when infection was not completely eradicated. Histologically, tibia from the treated animals showed less dead bone, much less fibrous tissue reaction, better capillary regeneration, and well-organized repair by trabecular bone. All treatment groups showed improvement over the control animals but the most significant results were obtained in those receiving three daily treatments for two hours at two atmospheres pressure. This suggested that frequency rather than the pressure used was the most important factor and that the treatment produced some alteration in the host response to the disease rather than a direct effect on the infecting organism.
A study of the pathology of chronic osteomyelitis shows the therapeutic problem to be more one of chronic ischmmia than of chronic sepsis. Viable bacteria may be retained in dead bone sequestra, rigid-walled abscess cavities, fibrin clot in cancellous spaces, and in avascular scar tissue. In all these sites blood-borne chemotherapeutic drugs may not be able to reach the bacteria, which at any time may cause a recrudescence of the disease. At the present time the disease may be treated by surgical attack, antibiotics, hyperbaric oxygen or, possibly best of all, a combination of all three. Each method has advantages and disadvantages.
Surgical treatment, when well-planned and suitably radical, will remove large sequestra, decompress abscess cavities, excise scar tissue, and drain pus when present. Where it sometimes fails is in the eradication of more generalized diffuse bone disease, and in the removal of small sequestra when these are surrounded by otherwise healthy bone; and it may be inapplicable in certain anatomical sites, particularly when ablation of otherwise healthy limbs may result.
In antibiotic treatment the initial successful results with penicillin were followed by the emergence cf resistant organisms but this problem has since been overcome by the development of the synthetic penicillins and other antibiotics. Recently, bone-seeking antibiotics such as Section ofOrthopedics 1203 lincomycin and fucidin have been advocated for the treatment of chronic disease as they have been shown to reach therapeutic levels by diffusion within bone. Thus, these antibiotics will kill bacteria in vascularized tissue, and diffuse short distances in bone, and are therefore valuable in overcoming acute exacerbations in the chronic disease. What they will not do is to penetrate large bone sequestra and avascular scar tissue, or reach therapeutic levels in abscess cavities. It is easier to be certain of what hyperbaric oxygenation will not do rather than what it will do. It will not resorb large sequestra, remove bony cavities, or kill aerobic bacteria in the exposure times that can be tolerated in man. On the basis of experimental evidence we can suggest that it will resorb smaller areas of dead bone or assist in the separation of bone sequestra, it may well revascularize fibrous scar tissue, and there is some evidence from tissue culture studies that it will stimulate new bone formation (Hamblen 1970) .
Hyperbaric oxygenation has been used in the treatment of 18 cases of chronic pyogenic osteomyelitis. No detailed results are presented as the patients came from various sources, their follow up has been incomplete, and in such a variable disease it would be wrong to draw conclusions from a short-term study. It is, however, valuable to consider 3 cases which illustrate the possible place of this therapy in the overall management of the disease.
Case 1: A 24-year-old soldier had been shot in the left leg by a high velocity missile causing extensive soft-tissue damage with large entry and exit wounds and a severely comminuted fracture of the tibia. The wounds were heavily infected by Staph. pyogenes and Ps. pyocyanea and, despite antibiotic therapy and the removal of one large sequestrum from the tibia, profuse discharge continued. Two months after wounding he received twelve two-hour treatments at three atmospheres in a six-day period. The treatment was then discontinued because of convulsions. His wounds became clean and it was possible to undertake split skin grafting, with 100% take. One month later there was no clinical evidence of sepsis and a bypass bone graft was performed through tissues which were described as noncedematous. Healing occurred by primary intention. As in all the cases, the antibiotic therapy was unchanged throughout the period of treatment. The successful outcome in this case was probably due to the short history with a combination of surgical excision, antibiotic treatment and production of adequate tissue oxygenation, allowing healing by vascular granulation tissue instead of avascular fibrous scar tissue.
Case 2: A 60-year-old vagrant had an unhealed chronic osteomyelitis of the right femur with intermittent abscess formation and discharge since the age of 13. There was a mixed infection, predominantly proteus and Str. fecalis, which had not responded to ampicillin therapy. Treatment with hyperbaric oxygenation was given as a last resort to avoid high thigh amputation. He received 35 two-hour exposures at two atmospheres pressure in a 30-day period. The sinus did not heal but the surrounding skin became more healthy and elastic, drainage decreased rapidly, and his sedimentation rate fell from 106 to 56 mm in 1 hour (Westergren). The patient declined further treatment but returned two months later with an exacerbation of the infection and amputation had to be carried out. Severe longstanding disease does not respond to this treatment unless the anatomical site permits associated radical surgical debridement.
Case 3: A 30-year-old man had developed osteomyelitis of the fibula following surgical treatment of a fracture dislocation of the ankle. Despite cloxacillin treatment for six months and sequestrectomy, discharge continued from the lateral malleolus. He received 24 two-hour treatments at two atmospheres pressure during an 18-day period. Initially, wound discharge increased and, despite improvement in the condition of surrounding soft tissue and skin, was still continuing at the end of treatment. A further sequestrum in the fibula was seen on X-ray and at surgical removal was noted to be lying in a dry bed, a similar finding to the animal experiments suggesting an improved reaction in the surrounding healthy tissues. The sinus healed within ten days, without further recurrence. The case demonstrates the need for surgical removal of large sequestra and the frequent continued improiement in healing some weeks after completion ofhyperbaric oxygen therapy.
No firm conclusions can be drawn from these early studies, though hyperbaric oxygen therapy may have a place in combination with surgery and antibiotics in the management of chronic osteomyelitis. A larger clinical study is needed, with careful bacteriological and hmmatological monitoring and elimination of as many other variables as possible. Such a study would require sufficient interest for cases to be collected in one centre.
